Alsnes IV, Janszky I, Forman MR, Vatten LJ, Okland I. A population-based study of associations between preeclampsia and later cardiovascular risk factors. Am J Obstet Gynecol. 2014;211(6):657.e1-7.
Belfort MA, Clark SL, Sibai B. Cerebral hemodynamics in preeclampsia: Cerebral perfusion and the rationale for an alternative to magnesium sulfate. Obstet Gynecol Surv. 2006;61(10):655-665.
Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007 Sep;92(9):3517-3522.
Bope ET, Kellerman RD, eds. Conn's Current Therapy 2014. 1st ed. Philadelphia, PA: Elsevier Saunders. 2013.
Cheng PJ, Huang SY, Su SY, Hsiao CH, Peng HH, Duan T. Prognostic value of cardiovascular disease risk factors measured in the first-trimester on the severity of preeclampsia. Medicine (Baltimore). 2016;95(5):e2653.
Ehrenberg HM, Mercer BM. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: A randomized controlled trial. Obstet Gynecol. 2006;108(4):833-838.
Ferri FF. Ferri's Clinical Advisor 2014. 1st ed. St. Louis, MO: Elsevier Mosby; 2013.
Habek D, Bobic MV, Habek JC. Oncocytic therapy in management of preeclampsia. Arch Med Res. 2006;37(5):619-623.
Harmon QE, Huang L, Umbach DM, et al. Risk of fetal death with preeclampsia. Obstet Gynecol. 2015;125(3):628-35.
Haugen M, Brantsaeter AL, Trogstad L, et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology. 2009 Sep;20(5):720-726.
Hladunewich MA, Derby GC, Lafayette RA, Blouch KL, Druzin ML, Myers BD. Effect of L-arginine therapy on the glomerular injury of preeclampsia: A randomized controlled trial. Obstet Gynecol. 2006;107(4):886-895.
Mendola P, Mumford SL, Mannisto TI, Holston A, Reddy UM, Laughon SK. Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth. Epidemiology. 2015;26(1):17-26.
Mihu D, Sabau L, Costin N, Ciortea R, Malutan A, Mihu CM. Implications of maternal systemic oxidative stress in normal pregnancy and in pregnancy complicated by preeclampsia. J Matern Fetal Neonatal Med. 2012;25(7):944-951.
Mor O, Stavsky M, Yitshak-Sade M, et al. Early onset preeclampsia and cerebral palsy: a double hit model? Am J Obstet Gynecol. 2016;214(1):105.e1-9.
Nielsen LR, Muller C, Damm P, Mathiesen ER. Reduced prevalence of early preterm delivery in women with Type 1 diabetes and microalbuminuria -- possible effect of antihypertensive treatment during pregnancy. Diabet Med. 2006;23(4):426-431.
Pare E, Parry S, McElrath TF, Pucci D, Newton A, Lim KH. Clinical risk factors for preeclampsia in the 21st century. Obstet Gynecol. 2014;124(4):763-70.
Patrelli TS, Dall'asta A, Gizzo S, et al. Calcium supplementation and prevention of preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med. 2012;25(12):2570-2574.
Podymow T, August P. Hypertension in pregnancy. Adv Chronic Kidney Dis. 2007;14(2):178-190.
Rytlewski K, Olszanecki R, Lauterbach R, Grzyb A, Basta A. Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: A preliminary report. Basic Clin Pharmacol Toxicol. 2006;99(2):146-152.
Shalom G, Shoham-Vardi I, Sergienko R, Wiznitzer A, Sherf M, Sheiner E. Is preeclampsia a significant risk factor for long-term hospitalizations and morbidity? J Matern Fetal Neonatal Med. 2013;26(1):13-15.
Staff AC, Berge L, Haugen G, et al. Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand. 2004;83:103-107.
Sween LK, Althouse AD, Roberts JM. Early-pregnancy percent body fat in relation to preeclampsia risk in obese women. Am J Obstet Gynecol. 2015;212(1):84.e1-7.
Teran E, Hernandez I, Nieto B, et al. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int JGynaecol Obstet. 2009;105:43-5.
von Dadelszen P, Menzies J, Gilgoff S, et al. Evidence-based management for preeclampsia. Front Biosci. 2007;12:2876-2889.
Weissgerber TL, Gandley RE, McGee PL, et al. Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population. PLoS One. 2013;8(4):e60479.
Xu H, Perez-Cuevas R, Xiong X, et al; INTAPP study group. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol. 2010 Mar;202(3):239.e1-239.e10. [Epub ahead of print].